SM
Sabby Management’s Arcadia Biosciences RKDA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-40,300
| Closed | -$89.1K | – | 49 |
|
2024
Q1 | $89.1K | Sell |
40,300
-57,005
| -59% | -$126K | 0.05% | 28 |
|
2023
Q4 | $305K | Buy |
97,305
+64,600
| +198% | +$202K | 0.3% | 14 |
|
2023
Q3 | $110K | Sell |
32,705
-85,508
| -72% | -$286K | 0.08% | 38 |
|
2023
Q2 | $459K | Buy |
118,213
+65,339
| +124% | +$254K | 0.38% | 25 |
|
2023
Q1 | $395K | Buy |
+52,874
| New | +$395K | 0.34% | 22 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 101 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 93 |
|
2022
Q1 | – | Sell |
-252,953
| Closed | -$263K | – | 116 |
|
2021
Q4 | $263K | Buy |
+252,953
| New | +$263K | 0.04% | 75 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 121 |
|
2021
Q2 | – | Sell |
-67,136
| Closed | -$185K | – | 109 |
|
2021
Q1 | $185K | Buy |
67,136
+34,633
| +107% | +$95.4K | 0.04% | 71 |
|
2020
Q4 | $82K | Sell |
32,503
-242,620
| -88% | -$612K | 0.02% | 49 |
|
2020
Q3 | $770K | Buy |
275,123
+215,580
| +362% | +$603K | 0.11% | 36 |
|
2020
Q2 | $224K | Buy |
+59,543
| New | +$224K | 0.05% | 36 |
|
2019
Q4 | – | Sell |
-50,000
| Closed | -$234K | – | 64 |
|
2019
Q3 | $234K | Buy |
50,000
+30,000
| +150% | +$140K | 0.13% | 47 |
|
2019
Q2 | $61K | Buy |
+20,000
| New | +$61K | 0.08% | 55 |
|
2019
Q1 | – | Sell |
-95,682
| Closed | -$303K | – | 85 |
|
2018
Q4 | $303K | Sell |
95,682
-181,499
| -65% | -$575K | 0.07% | 44 |
|
2018
Q3 | $1.36M | Buy |
277,181
+155,491
| +128% | +$760K | 0.17% | 18 |
|
2018
Q2 | $1M | Sell |
121,690
-28,686
| -19% | -$237K | 0.16% | 27 |
|
2018
Q1 | $3.61M | Buy |
+150,376
| New | +$3.61M | 0.43% | 7 |
|